82% of women don’t know how many gynaecological cancers there are so spread the word – its Gynaecological Cancer Awareness Month!
This month marks the first-ever Gynaecological Cancer Awareness Month and The Eve Appeal gynaecological cancer charity in association with all for eve need your ‘kisses’!
Recent research has shown that 82% of UK women do not know how many gynaecological cancers there are. This is especially concerning given that 18,000 women are diagnosed with a gynaecological cancer in the UK every year and of these, 7,500 will die.
The Eve Appeal, the only national charity dedicated to raising funds and awareness of all gynaecological cancers, has launched a new annual campaign with ‘a touch of red’ theme. The focus of this year’s campaign, the kiss of life, aims to collect 7,500 ‘kisses’ – one for every woman lost to gynaecological cancer each year in the UK.
There are opportunities for everyone to get involved in the campaign:
- Text ‘EVE’ to 70800 for a link to download our free iPhone app to send kisses to family and friends (£1 per kiss)
- Free download of the kiss of life iPhone app from The App Store (£1 per kiss)
- Upload a photo of your own kiss or chose a pre-set kiss image to send to a loved one via www.gcam11.org.uk (£1 per upload)
- Put on your favourite lipstick and kiss a card (available from 020 7299 4430 or www.gcam11.org.uk) and post to The Eve Appeal for a minimum donation of £2. The charity will upload the card to the website
- Text ‘KISS11 £2’ to 70070 to donate
SaysRobert Marsh, CEO of The Eve Appeal, “We know that earlier diagnosis of gynaecological cancers can help save lives so come on ladies – please start talking, and break down that wall of embarrassment that could put your lives at risk.”
Help us to help women by sending a ‘kiss’ to raise funds and awareness. It’s so easy – just go to www.gcam11.org.uk and follow the instructions.
“all for eve are dedicated to raising funds and awareness for The Eve Appeal and we are proud to use our association with the charity to promote the launch of the first gynaecological cancer awareness month in order to increase the flow of donations to the cause.” – Liz Hotchin, Brand Manager, all for eve
Release date: 2 September 2011
Further information: email@example.com
07812 150832/0208 663 1040
Notes to Editors
About The Eve Appeal
The Eve Appeal was publicly launched in 2005 to help save women’s lives by funding research into gynaecological cancers and raising awareness of the diseases. The charity is well on its way to meeting its original fundraising target of £5 million.
But there is still much to do. Much of the research work now under way will not be completed for some years and continued funding is essential if its early promise is to be fulfilled.
For the future The Eve Appeal continues to work towards its vision of a world where fewer women develop and more women survive gynaecological cancers.
About all for eve
‘all for eve’ is the result of a unique business concept developed and launched by George Hammer, Chairman of The Urban Retreat Group in 2009. The beauty brand’s sole purpose is to raise funds and awareness for gynaecological cancer research by donating all its net profits to The Eve Appeal. Created as a direct response to the death of his sister-in-law to ovarian cancer in 2008, George is determined to help change the future lives of woman throughout theUK so that other families do not have to endure the heartache his family has had to.
Eve Red Lipstick
Available at feelunique.com and allforeve.co.uk, not only is this lipstick long lasting but all net profits from its sales go directly to The Eve Appeal – supporters will be making a double donation, what could be better than that!
 Conducted by The Eve Appeal
Liz Engel, Press Office
The Eve Appeal
Direct: 020 8663 1040
Mobile: 07812 150832
Switchboard: 020 7299 4430
The Eve Appeal was set up to fund groundbreaking research into all gynaecological cancers at the Gynaecological Cancer Research Centre, UCL.
Our vision is a world where more women survive and fewer women are diagnosed with gynaecological cancers.